Ivonescimab 10 mg/kg
PrE0510
Phase 2 small_molecule active
Quick answer
Ivonescimab 10 mg/kg for Extensive Stage Lung Small Cell Cancer is a Phase 2 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Extensive Stage Lung Small Cell Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active